Beneficiaries (2020-2024)

No.

Partner

Division

VU University Amsterdam

AIMMS/ Medicinal Chemistry

VU University Amsterdam

AIMMS/ Medicinal Chemistry

Centre National de la Recherche Scientifique (CNRS)

Institut de Génomique Fonctionnelle

Centre National de la Recherche Scientifique (CNRS)

Institut de Génomique Fonctionnelle

Max Delbrück Center für Molekulare Medizin

Receptor Signaling Group

Max Delbrück Center für Molekulare Medizin

Receptor Signaling Group

Universitätsklinikum Jena

Molecular Cell Biology

Universitätsklinikum Jena

Molecular Cell Biology

University of Nottingham

School of Life Sciences / Molecular Pharmacology

University of Nottingham

School of Life Sciences / Molecular Pharmacology

Universidad Autonoma de Madrid

Molecular Biology

Universidad Autonoma de Madrid

Molecular Biology

Institute National de la Sante et de la Recherche Medicale (INSERM)

Research Lab

Institute National de la Sante et de la Recherche Medicale (INSERM)

Research Lab

University of Glasgow

College of Medical, Veterinary and Life Sciences College / Molecular Pharmacology

University of Glasgow

College of Medical, Veterinary and Life Sciences College / Molecular Pharmacology

QVQ Holding BV

Research Lab

QVQ Holding BV

Research Lab

InterAx Biotech AG

Research Lab

InterAx Biotech AG

Research Lab

Follow us on

ONCORNET2.0Follow

Retweet on Twitter ONCORNET2.0 Retweeted

Avatar David Gloriam @David_Gloriam·

28 May

New review on #gpcr structural dynamics out in COSB. Great teamwork with the @JanaSelent group. Thanks to @Lundbeckfonden and @novonordiskfond https://lnkd.in/eyjrA5V

Reply on Twitter 1398230218188496901 Retweet on Twitter 13982302181884969012 Like on Twitter 139823021818849690112 Twitter 1398230218188496901

Retweet on Twitter ONCORNET2.0 Retweeted

Avatar British Pharmacological Society @BritPharmSoc·

28 May

A reminder that applications for our new Deputy Editor in Chief of #PharmacologyMatters close on Monday. https://buff.ly/2PNWf4V

Reply on Twitter 1398237377596956672 Retweet on Twitter 13982373775969566725 Like on Twitter 13982373775969566728 Twitter 1398237377596956672

Avatar ONCORNET2.0 @ONCORNET1·

28 May

ONCORNET2.0 is the successor to #ONCORNET. You can see some of the work of ESRs from the first ONCORNET in this special issue of @MolPharmJournal from 2019, with reviews on #CXCR4 and #ACKR3 structure and function: https://molpharm.aspetjournals.org/content/96/6

Reply on Twitter 1398237499756003329 Retweet on Twitter 13982374997560033291 Like on Twitter 13982374997560033293 Twitter 1398237499756003329

Avatar ONCORNET2.0 @ONCORNET1·

28 May

Hi everyone – we’re on Twitter! ONCORNET2.0 is a #MarieCurie ITN of 16 ESRs across Europe studying #chemokine #GPCRs #CXCR4 and #ACKR3 in cancer. Our projects cover molecular dynamics, medchem, #pharmacology through to translational work. Follow us for updates from our ESRs!

Reply on Twitter 1398206898764140544 Retweet on Twitter 13982068987641405444 Like on Twitter 139820689876414054415 Twitter 1398206898764140544

Retweet on Twitter ONCORNET2.0 Retweeted

Avatar Steve Briddon🧪🔬📷🎧💙@Hebdomadian·

18 May

Hi everyone!

Public service announcement: our Marie-Curie ITN @ONCORNET1 is on Twitter! The 16 wonderful #ECRs working on the project will soon be Tweeting about #GPCR #chemokine #ECR life and #pharmacology

Please #RT & consider a follow or follow back! 🙏😀

Reply on Twitter 1394758596110471173 Retweet on Twitter 13947585961104711739 Like on Twitter 139475859611047117314 Twitter 1394758596110471173

Contact details

Please contact us at:
info@oncornet.eu

ONCORNET Coordinator
VU University Amsterdam
The Netherlands

Funded by

Marie Curie Actions

EU Horizon 2020

European Union